CHAPEL HILL, N.C.--(BUSINESS WIRE)--Nov. 3, 2004--POZEN, Inc.
(NASDAQ: POZN) announced today that William L. Hodges the company's
senior vice president of finance and administration and chief
financial officer will be speaking to investors at the CIBC World
Markets Healthcare Conference in New York on Monday, November 8, 2004
at 8:30 a.m. Eastern Time. POZEN's presentation will be webcast and
archived on POZEN's home page at www.pozen.com.
POZEN is a pharmaceutical company committed to developing
therapeutic advancements for diseases with unmet medical needs where
it can improve efficacy, safety, and/or patient convenience. Since its
inception, POZEN has focused its efforts primarily on the development
of pharmaceutical products for the treatment of migraine. POZEN is
also exploring the development of product candidates in other
pain-related therapeutic areas. POZEN has development and commercial
alliances with GlaxoSmithKline, Xcel Pharmaceuticals, and Nycomed. The
company's common stock is traded on The Nasdaq Stock Market under the
symbol "POZN". For detailed company information, including copies of
this and other press releases, see POZEN's website: www.pozen.com.
Bill Hodges, 919-913-1030
Chief Financial Officer
Fran Barsky, 919-913-1044
Director, Investor Relations